Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)-Reference-Cited by-同舟云学术

Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)

Published:2014-11 Issue:9 Volume:114 Page:1329-1338
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Lee Joo Myung,Park Kyung Woo,Han Jung-Kyu,Yang Han-Mo,Kang Hyun-Jae,Koo Bon-Kwon,Bae Jang-Whan,Woo Sung-Il,Park Jin Sik,Jin Dong-Kyu,Jeon Dong Woon,Oh Seok Kyu,Park Jong-Seon,Kim Doo-Il,Hyon Min Su,Jeon Hui-Kyung,Lim Do-Sun,Kim Myeong-Gon,Rha Seung-Woon,Her Sung-Ho,Hwang Jin-Yong,Kim Sanghyun,Choi Young Jin,Kang Jin Ho,Moon Keon-Woong^ORCID,Jang Yangsoo,Kim Hyo-Soo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial;Stone;J Am Coll Cardiol,2011

2. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial;Byrne;J Am Coll Cardiol,2011

3. 2-Year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial;Jensen;J Am Coll Cardiol,2012

4. 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

5. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial;Silber;Lancet,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions;International Journal of Cardiology;2020-02

2. Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock;PLOS ONE;2019-04-03

3. Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?;Sports Medicine;2019-02-05

4. One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis;Catheterization and Cardiovascular Interventions;2019-01-02

5. Non-Inferiority of Resolute Integrity Drug-Eluting Stent to Benchmark Xience Drug-Eluting Stent;Circulation Journal;2018-08-24